Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04289636
Other study ID # 1569066
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date July 13, 2021

Study information

Verified date August 2021
Source The Miriam Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the feasibility of two approaches for improving long-term weight loss success among individuals with severe obesity. All participants will receive a 15-week, standard behavioral weight loss program followed by either 8 weeks of a mindfulness self-compassion intervention or 8 weeks of a nutrition and cooking education intervention (determined via randomization procedures). Assessments of weight, physical activity, and other weight-related and psychosocial factors will occur at baseline, 4 months, 6 months, and 9 months.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date July 13, 2021
Est. primary completion date April 9, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age 18-65 years - BMI between 40 - 55 kg/m2 - Female - Score high on internalized weight bias Exclusion Criteria: - Presence of any condition that would limit one's ability to exercise (i.e., orthopedic limitations) - Recent weight loss (=15 pounds within the past 6 months) - History of bariatric surgery - Current or recent enrollment (completed <1 year ago) in a weight loss program at the Weight Control and Diabetes Research Center - Currently taking any weight loss or other medication that could alter one's metabolism - Women who are pregnant, planning on becoming pregnant in the next 6 months, or those pregnant within the past 6 months - Serious psychiatric disorder (e.g., psychosis, major depression, suicidality) - - Participants with a history of diabetes or heart disease will be considered for this study only if their heart disease or diabetes is well controlled, and physician consent will be required.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Behavioral weight loss program
Using a combination of individual (~1x/month) and group-based (~3x/month) meetings, participants will be taught behavioral approaches for changing diet and exercise behaviors. This intervention will be 15 weeks in duration and will be delivered remotely using a video-conferencing platform.
Self-compassion
This 8-week, group-based program will help train individuals on how to handle difficult emotions with greater ease, how to transform difficult relationships, and how to motivate and encourage oneself, rather than being self-critical.
Nutrition and cooking education
This 8-week, group-based program will help individuals to improve the quality of their diet through nutrition education and basic cooking skills for preparing healthy meals.

Locations

Country Name City State
United States The Miriam Hospital's Weight Control and Diabetes Research Center Providence Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
The Miriam Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment feasibility will be assessed by the number of participants screened and enrolled Recruitment feasibility will be assessed by the number of participants screened and enrolled At the end of the study, up to 9 months post-baseline
Primary Session attendance will be assessed by calculating the overall session attendance (# of sessions completed/# of sessions possible). The feasibility of the intervention will be assessed by calculating the overall session attendance 6 months
Primary Acceptability of the intervention (retention) will be determined by the percentage of participants completing the 9-month assessment visit Acceptability of the intervention (retention) will be determined by the percentage of participants completing the 9-month assessment visit 9 months
Secondary Percent weight change at 6 months 6 months after study enrollment
Secondary Percent weight change at 9 months 9 months after study enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2